Emerging investigations areing on specially designed amino acid sequences, a distinct class of agents demonstrating significant potential for targeting multiple condition pathways. Compared to existing drug techniques, Nexaph peptides offer improved targeting and minimal unintended consequences, enabling them a highly desirable pathway for next-gen